Phototherapy & Mogamulizumab in Early Stage MF (PLIGHT)

See also
Status	Clinical Trial	Phase
Terminated	`NCT02890368` - Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides	Phase 1
Not yet recruiting	`NCT02881749` - Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides	Phase 2
Completed	`NCT00051012` - Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients	Phase 4
Terminated	`NCT03789864` - Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides	N/A
Completed	`NCT01590732` - Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma	Phase 1
Recruiting	`NCT02848274` - ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Recruiting	`NCT00177268` - Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Recruiting	`NCT05357794` - Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides	Phase 2
Completed	`NCT04955340` - A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat	Phase 1
Recruiting	`NCT04960618` - Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome	Phase 2
Completed	`NCT02883517` - Cell-free Circulating DNA in Primary Cutaneous Lymphomas
Active, not recruiting	`NCT02953301` - Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)	Phase 2
Completed	`NCT00254332` - Effect of Denileukin Diftitox on Immune System in CTCL Patients	N/A
Completed	`NCT02296164` - Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
Recruiting	`NCT05680558` - Photopheresis in Early-stage Mycosis Fungoides	Phase 2
Completed	`NCT00038376` - Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies	Phase 2
Completed	`NCT00168064` - Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides	Phase 2
Recruiting	`NCT05879458` - Ritlecitinib in CTCL	Phase 2
Recruiting	`NCT05904522` - Histopathological Changes in Mycosis Fungoides	N/A
Recruiting	`NCT05414500` - Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides	Phase 1

NCT number	NCT06235281
Study type	Interventional
Source	H. Lee Moffitt Cancer Center and Research Institute
Contact	Ashley Kuruvilla
Phone	813-745-6003
Email	ashly.kuruvilla@moffitt.org
Status	Recruiting
Phase	Early Phase 1
Start date	January 18, 2024
Completion date	September 1, 2029

Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) — PLIGHT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms